Why Novo Nordisk A/S (NVO) Stock Rose 2.4% on November 13, 2026
+2.41%$41.63November 13, 2026 · S&P 500 -0.36%
The short answer
Novo Nordisk A/S (NVO) stock is up 2.4% to 41.63 during the November 13, 2026 session, while the S&P 500 ETF (SPY) is down 0.4%. This move is significantly larger than the overall market's and in the opposite direction, suggesting it is primarily specific to NVO or its industry. Reports indicate that Novo Nordisk has scored a win in the EU for a hemophilia drug and is advancing a sickle cell treatment toward approval, which may be the likely reason for the stock's positive performance.
The news behind it
Before you buy or sell
Get a second opinion on NVO
The bull case, the bear case and a verdict, with the numbers, in 10 seconds. Free →
Don't miss the next one
Alert me when NVO moves
Price, RSI and volume alerts by email or push. Free plan →
Full market recap for November 13, 2026 · What's moving NVO today
Written from that session's quote and the headlines listed above. Educational, not financial advice.